Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Recruiting 3Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 180Breast Neoplasms 173Carcinoma, Non-Small-Cell Lung 172Colorectal Neoplasms 104Stomach Neoplasms 80Pancreatic Neoplasms 78Lung Neoplasms 78Prostatic Neoplasms 74Melanoma 67Recurrence 65Leukemia, Myeloid, Acute 65Neoplasm Metastasis 64Multiple Myeloma 63Ovarian Neoplasms 61Carcinoma, Hepatocellular 61Advanced Solid Tumor 59Lymphoma 58Advanced Solid Tumors 56Solid Tumor 50Lymphoma, Non-Hodgkin 47Uterine Cervical Neoplasms 45Glioblastoma 44Lymphoma, B-Cell 39Leukemia 38Head and Neck Neoplasms 34Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Esophageal Neoplasms 30Urinary Bladder Neoplasms 29Squamous Cell Carcinoma of Head and Neck 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Advanced Prostate Cancer × Clear all
NCT06006104 2023-08-23

Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1/2 Unknown
49 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡